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Abstract The questionnaire format applied in a CV study
represents the way in which the WTP estimates are
obtained. Payment scales are often used in CV studies as
the questionnaire format of choice. The study summarized
here analyzes the impact of the design of two payment
scales (PS) on the monetary value of QALY gains. The
scales differed in terms of their end-points, mid points, and
coarseness. We judged the performance of the two PS
against several indicators: the average WTP per QALY
estimates, post-estimation uncertainty levels, the existence
of mid-point concentration, and the dependency on end-
points. Our results show that PS design influences
respondents’ WTP values. The results also suggest that a
more detailed scale with a more realistic range may help
respondents to elicit values closer to their ‘‘true’’ WTP
values, hence produce higher-quality outcomes. Further
research and pretesting strategies are suggested to explore
and minimize the effects of PS design on WTP estimates,
which may ultimately increase the quality of WTP
estimates.
Keywords Payment scale  Willingness to pay  QALY 
Uncertainty  Bias  Contingent valuation  Preferences
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Introduction
Contingent valuation (CV) is a stated preference method
that enables researchers to directly estimate the monetary
value of a non-market good or service, either by asking
respondents for their willingness to pay (WTP) for
obtaining a good, or their willingness to accept (WTA) for
giving it up (e.g., [15]). Many CV studies have been
published in the field of health economics (e.g., [22]), of
which a considerable number concerned valuing health
gains (e.g., [7, 28, 34, 36, 42, 49, 53, 61, 68]). Although a
carefully designed CV study can provide useful input for
decision-making in healthcare (e.g., [14]), CV studies
involve a number of methodological issues (e.g.,
[8, 25, 29, 46, 57, 63, 64, 66]). One of the design-related
issues concerns the appropriate questionnaire format
applied in CV studies. The questionnaire format refers to
the technique with which the WTP estimates are elicited.
The main questionnaire formats used in CV studies are the
bidding game (BG), the dichotomous choice (DC) format,
the open-ended (OE) format, and the payment scale (PS)
format. Here we focus on the PS format, which was shown
to have several advantages over the other questionnaire
formats, as will be briefly discussed below.
Using a PS, an analyst presents a specified range of
monetary values and asks respondents to select a value that
best represents the amount they would be willing to pay for
a specified benefit (e.g., [7, 56]). Mitchell and Carson [44]
first proposed the PS and it has been used widely in dif-
ferent fields (e.g., [9, 20, 62]). Compared to BG and DC,
PS avoids the starting point bias, since the question does
not offer an initial bid to be used as an anchor, and avoids
‘yea-saying’, since a yes–no question is not posed
[10, 16, 64]. PS can also conserve respondents effort
because even a fairly detailed set of values offered on a PS
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can be visually scanned quite quickly, and given the sim-
plicity of the question, there is no need for prompting by an
interviewer [12]. PS can also reduce the high rate of item
non-response in the OE format [21] since it is cognitively
less demanding than formats not employing numerical
cues. However, although they may reduce the cognitive
burden, numerical cues offered on a PS provide respon-
dents with a ‘‘comprehensible context’’ for eliciting their
WTP values, which can significantly impact the outcome of
a CV study [63, 66]. For instance, respondents may view
the range of values offered on a PS as representing ‘‘rea-
sonable’’ amounts for their WTP [45]. If, compared to the
values presented on the PS, respondent’s true WTP value is
relatively low, they may interpret it as being too low and,
subsequently, choose to report a relatively higher WTP in a
hypothetical exercise. The opposite of course is also pos-
sible. In this way, the PS range may result in respondents
revising their true WTP estimates up- or downwards [66].
The more sensitive responses are to the provided ranges,
the higher the likelihood of obtaining inaccurate WTP
estimates [48].
However, to what extent are WTP estimates for health
gains sensitive to the ‘‘comprehensible context’’ of PS
design? Moreover, if WTP is sensitive to PS design, how
can we discern which particular design of PS performs
better? What can analysts do to reduce the dependency of
WTP on PS design? The study summarized here was
designed to explore these issues. Because there is no gold
standard for designing the PS, improving our understand-
ing of the effects different PS designs can have on WTP
estimates, using different methods of pretesting PS scales,
will reduce the uncertainty regarding the impact of PS on
the final outcome of CV studies. Ultimately, since the
majority of CV studies are undertaken to inform policy-
making (e.g., [14]), more accurate WTP estimates can help
improve decision-making based on social preferences.
Our exploration is in the domain of valuing health gains,
expressed in terms of quality-adjusted life-years (QALYs).
We start our exploration with an overview of the existing
evidence on the effects of PS designs on WTP. We then
formulate our hypotheses and explore the impact of two
different PS designs on WTP per QALY estimates and
analyze which design could be considered better, and why.
Finally, we discuss our results and their implications for the
process of pretesting payment scales in CV studies.
Previous research and the contribution
of the current study
Although many studies compared the performance of dif-
ferent payment formats on WTP estimates (e.g., PC vs. DC
by [13, 32]; OE vs. PC by [21, 26, 30]), a relatively small
number of studies directly explored the effect of different
features of PS design on WTP estimates.1 In the area of
environmental economics, two studies confirmed that PS
end-points may influence WTP estimates. Rowe et al. [54]
explored the differences in WTP estimates obtained using
four otherwise-equal PS with end-points of $200, $1000,
$5000, and $10,000, and found a significant difference in
WTP obtained between the PS with the lowest end-point
($200) and those with the three higher end-points. Dubourg
et al. [23] also reported a significant difference in WTP
estimates between two PS with different end-points (£1500
and £500). The scale with a three times higher end-point
yielded a 2.65 times higher average WTP value as com-
pared to the scale with the lower end-point. The only study
in the field of health economics that explored the effect of
the design of PS on WTP estimates was the study by Smith
[63]. This study focused on the impact of the ordering of
PS value points on WTP estimates and showed that a PS
with value points ordered from high-to-low increases the
WTP as compared to a PS with either low-to-high or ran-
domly sorted values.
Our study most resembles the study by Dubourg et al.
[23], although there are important differences. First,
Dubourg et al. [23] elicited WTP values from 94 respon-
dents, whereas we use data from over 1000 respondents
representative of the adult population of the Netherlands,
which increases the reliability and generalizability of the
results. Secondly, our study elicited WTP values in a two-
step procedure, combining the PS with a follow-up OE
question. Using a single PS, respondents were asked to first
indicate the maximum amount they would definitely pay
for a given QALY gain, then to indicate the minimum
amount they would definitely not pay for this gain, and
finally asked for their exact WTP in a bounded follow-up
OE question. This OE-WTP was bounded by the minimum
and maximum values indicated on the PS, i.e., by the
‘‘value gap’’ over which respondents were uncertain (e.g.,
[23]), and was taken as the estimate of individual WTP for
calculation of WTP per QALY values.2 The two-step
approach may be preferred to a single PS, for several
reasons. First, the OE-WTP is elicited after considering the
PS, arguably leading to more thought-through answers.
Second, the approach generates a richer data set with
multiple valuations per respondent. For our current study,
the data allows us to test the impact of the design of PS
both on the width and the position of the PS-WTP value
gap, and on the final OE-WTP estimates (as described in
1 Other studies have explored the effect of different types of scales
(e.g., VAS scales, rating scales) on preferences and attitudes other
than WTP, for example Lee et al. [38], Aguinis et al. [1], Hui and
Triandis [33].
2 Here, the minimum and maximum values obtained using PS are
primarily relevant as intervals surrounding OE values.
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the next section). Hence, the ‘‘goodness’’ of the PS scale
design need not be inferred from the differences between
the WTP point estimates obtained using different PS
designs, but from the effect a particular PS design has on
the respective OE-WTP or the value gap.
A final difference of this study with Dubourg et al. [23]
was that along with every OE-WTP question we recorded
the post-estimation response certainty surrounding the
WTP estimates. Respondents were asked how certain they
were about actually paying OE-WTP if asked right now,
with response options: (1) totally certain I would pay; (2)
pretty certain I would pay; (3) maybe yes, maybe no; (4)
probably would not pay; (5) surely would not pay. The
relationship between response uncertainty and WTP esti-
mates is important because lab and field experiments have
shown that WTP estimates accompanied by a higher level
of response certainty better predict actual consumption
behavior (e.g., [5, 6]) and the measure of uncertainty could
be used to calibrate the hypothetical WTP and obtain the
actual values (e.g., [2, 58]). It has also been suggested that
issues such as range bias may be mitigated by restricting
the analysis to the WTP values of those respondents who
indicate they are ‘definitely sure’ they would pay their
stated WTP [59], since these respondents may exhibit less
anomalous behavior. Given the potential importance of
response certainty, we explore whether a particular PS
design fosters more response certainty.
Generally, comparisons between different payment scale
designs may lead to two main outcomes. First, if we find no
significant differences between PS, our focus may turn to
understanding which scale is relatively most cost-effective to
be used in surveys. If we find a significant difference between
payment scales, then we must discern which scale design, if
any, is preferred. By looking at comparisons beyond themean
WTP, this study attempts to address these questions.
PS design and hypotheses
We designed two payment scales, labeled PS-5 and PS-
25 (Fig. 1) and randomly assigned 1015 respondents to
either PS (details of the design and sampling are pre-
sented below). The payment scales accompanied other-
wise identical WTP questions and a two-step approach
was applied to elicit WTP, as described above, yielding
the following estimates of the QALY gain on offer
(Fig. 1):
– PS-5L,A and PS-25L,A indicating the average maximum
amount a respondent would pay (lower bound of the
value gap);
– PS-5U,A and PS-25U,A indicating the average minimum
amount a respondent would not pay (upper bound of
the value gap);
– OE-5A and OE-25A indicating average OE-WTP.
PS-5 and PS-25 mainly differed in terms of their end-
points (€500 in PS-5 vs. €2500 in PS-25) and the number of
value points (23 points on PS-5 and 16 on PS-25), making
PS-5 a considerably more detailed (less coarse) scale
(Fig. 1). PS-25 covered a wider range with fewer value
points, i.e., the average size of the interval between two
value points was larger for PS-25 than PS-5. The intervals
between value points were unevenly distributed along both
scales, with considerably wider intervals towards the end of
the scales. As a result, the mid-points of each scale differed
from the mid-point values (Fig. 1). Finally, PS-5 offered a
value point located exactly at the middle of the scale (i.e.,
the 12th value point) whereas the middle of PS-25 was
located between two value points (i.e., the 8th and the 9th
point).
Based on the points at which WTP values were elicited,
we formulate our hypotheses:
Fig. 1 PS-5 and PS-25: intervals and value points
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H1: Differences in design between PS-5 and PS-25 lead
to statistically different average WTP and WTP per
QALY estimates, with PS-25 leading to relatively higher
OE-WTP values.
There is evidence that the average WTP values are corre-
lated with the PS end-points (e.g., [23, 54]). We first test
whether the difference in WTP estimates are related to the
difference in the end-points of the scales.
H2: Differences in design between PS-5 and PS-25 lead
to a difference in response patterns.
Beyond testing the equivalence of mean WTP amounts,
this study looks at additional comparisons, such as vari-
ance, frequencies, distributions and the presence of
extreme values, along with response rates, item non-re-
sponse and proportion of protest responses—all additional
issues to consider when comparing the performance of two
payment scales.
H3: Differences in design between PS-5 and PS-25 lead
to difference in the central tendency of WTP values and
therewith to mid-point centering of OE-5A and OE-25A
estimates.
If respondents have stable, well-formed preferences, their
WTP value is expected to be independent from the PS
design. However, in case preferences are not stable or well
formed, respondents may resort to different heuristics and
construct a WTP value on the spot. They may use the mid-
point of the scale (€18 in PS-5 and €137.5 in PS-25, Fig. 1)
as a cue for forming a value. We investigate whether and
how respondents use the mid-point of the scale to form
their WTP values, and analyze the central tendency of
WTP responses.
H4: Differences in design between PS-5 and PS-25 are
associated with different levels of self-reported response
uncertainty, captured by the width of the respective
value gaps and the post-estimation certainty levels.
Arguably, a particular design of the payment scale may be
considered a better or worse vehicle for expressing pref-
erences. All other things being equal, one PS may foster
more certainty in stated preferences, for instance because it
offers numerical cues that respondents can ‘‘work with’’
(for instance, familiar values) and hence be of help in
expressing, or constructing, their preferences. Keeping
other important determinants of post-estimation response
uncertainty constant (sample representativeness, wording
of questions, payment vehicles, etc.), we investigate the
association between the self-reported uncertainty (i.e., size
of the value gap [31] and the distribution of response
uncertainty) and PS design.
Methods
A sample of 1015 respondents representative of the Dutch
population according to age (18–65 years), gender, and
education participated in this study (Table 1). The data was
collected through an online questionnaire as a part of a
wider study exploring the value of a QALY. The
Table 1 Summary statistics
Variable PS-5 PS-25
Mean SD Min Max Mean SD Min Max
Age (years) 42.2 13.1 18 65 39.3 12.4 18 65
Sex (female) 0.49 0.50 0.51 0.50
Married (yes) 0.62 0.49 0.55 0.50
Children (yes) 0.55 0.50 0.46 0.50
Number of childrena 2.07 0.93 1 5 2.06 1.26 1 15
Higher vocational or academic education (yes) 0.34 0.47 0.36 0.48
Employed (yes) 0.60 0.49 0.64 0.48
Household income (€) 2724 1694 999 10,000 2563 1501 999 10,000
(%\ €1000) 0.12 0.15
(% C €1000 and\ €2000) 0.34 0.34
(% C €2000 and\ €3500) 0.37 0.37
(% C €3500) 0.16 0.14
Number of people living on household income 4.25 2.72 1 13 4.01 2.53 1 13
EQ-5D (Dutch tariff) 0.85 0.23 0 1 0.85 0.23 0 1
EQ-VAS (1–100) 72.7 19.6 0 100 72.5 18.3 0 100
VAS visual analogue scale
a PS-5, n = 583; PS-25, n = 485
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questionnaire (see Appendix 1) asked respondents to solve
six WTP questions in total, including the question analyzed
here, which was presented as the third question. Respon-
dents were asked to value an individual (own) QALY gain
described by a difference between two EQ-5D health states
[24]. In total, 42 health states were combined into 29
scenarios, which were presented to respondents at random,
respecting scenario balance (Appendix 3).3 Respondents
were first asked to indicate which of the two health states
they considered as better and then asked to imagine being
in the better health state, but facing the risk of spending
1 year in the worse health state (i.e., either a 2, 4, 10, or
50 % risk), starting the next day. The concept of risk was
graphically explained to respondents at the beginning of
the survey (Appendix 2).4 The risk of the personal health
decrement could be reduced to zero by taking a painless
medicine once a month during the period of 1 year. The
medicine would have to be paid through an increase in their
health insurance premium, also during the period of 1 year
(i.e., in 12 monthly installments). Respondents were
reminded to take their household budget into consideration
as well as which elements of the budget (e.g., rent, food,
clothing, entertainment, education) they would need to
economize on. Moreover, in the introduction of the ques-
tionnaire, respondents were told that healthcare decision-
makers want to spend the healthcare budget in the best way
possible, and in order to do that, they are interested in how
people value different health states. It has been suggested
in the literature (e.g., [11, 40, 41]) that ‘‘consequentialism’’
and ‘‘cheap talk’’ approaches may reduce hypothetical bias.
For further details of the study design, we refer the reader
to the published results in Bobinac et al. [8, 9].
The expected QALY gain was calculated as the differ-
ence between the utility weights of health states 1 and 2
presented to respondents in each scenario, multiplied by the
level of risk. In the 29 scenarios, subjects valued expected
QALY gains ranging from 0.002 to 0.066; the average size
of the expected QALY gain did not differ between the
versions offering PS-5 and PS-25 (p[ 0.05, Table 2).
WTP per QALY estimates were calculated as a ratio
between OE-WTP and the expected QALY gain, for each
row of the data. Hence, all PS and OE-WTP values qualify
as ‘‘raw’’ WTP values, as they were read directly from the
questionnaire, unlike the WTP per QALY values, which
are a product of calculations.
Wilcoxon test (two independent samples) and paired t
tests were used to determine statistical difference between
the relevant values. To compare PS performance in terms
of response, z-tests were conducted to test for equal pro-
portions between the two payment scales. To explore
whether the range of the PS had a direct effect on WTP
estimates, ceteris paribus, a multivariate regression on PS-5
and PS-25 pooled data was performed, with OE-WTP as
the dependent variable:
OE-WTP ¼ b0 þ b1 expected QALY gainð Þ
þ b2 ageð Þ þ b3 incomeð Þ
þ b4 educationð Þ þ b5 genderð Þ
þ b6 dPSð Þ þ e:
While controlling for the expected QALY gain and
respondents’ income, the significance of dPS variable
would confirm the direct effect of the design of PS on
respondents’ maximum OE-WTP. All variables were tested
for the normality of distribution using Shapiro–Wilk test
and graphic interpretation of the Q–Q plot; if variables
were not normally distributed, these were log-transformed.
Multicollinearity between variables was analyzed using
Pearson’s correlation coefficients. The data was analyzed
using STATA 11.
Results
The yearly OE-5A was €636 (12 9 53) and OE-25A was
€1848 (12 9 154) (p = 0.00, Table 2), about three times
higher. The WTP per QALY was €277,200 from PS-5
and €404,400 from PS-25 (p = 0.00, Table 2), which is
approx. 55 % higher,5 confirming H1. Similar results
were obtained from the regression analysis (Table 3,
model 1).6 When controlling for other important deter-
minants, PS-25 yielded a 245 % (i.e., exp0.896) higher
3 The 29 scenarios were obtained by combining 42 different EQ-5D
states and four probability levels (i.e., 2, 4, 10, and 50 %),
representing a fair spread of QALY gains across the utility plane.
The scenarios were previously used in deriving the British [35] and
Dutch [37] EQ-5D tariffs and used by Gyrd-Hansen [28] in her study
of WTP per QALY in Denmark.
4 A visual aid using dots in explaining the concept of risk was
demonstrated to increase the validity of WTP responses by Corso
et al. [17]. Our design of this graphical explanation was similar to that
used in the recent EuroVaQ project, see http://research.ncl.ac.uk/
eurovaq/EuroVaQ_Final_Publishable_Report_and_Appendices.pdf.
5 The difference in OE-WTP values between PS-5 and PS-25 was
approx. a factor three, but the difference in WTP per QALY values
was approx. a factor 1.5. This was due to the ‘‘mean of ratios’’ method
employed in the calculation (i.e., the mean of ratios calculated for
each row of data), suggesting that respondents estimated OE-WTP
values that are non-proportional to the size of the expected QALY
gain. Employing the ‘‘ratio of means’’ method, on the contrary, would
lead to a proportional difference (i.e., factor three), but would not
account for the distribution of individual values.
6 With respect to the other variables presented in Table 3, the
independent variable LN(health gain) is significant and positive,
pointing to the theoretical validity of our findings, although non-
proportional in relation, signaling scope insensitivity [8]. LN(income)
was also significant: on average, in case a household income was
10 % higher, the respondents were willing to pay 6.9 % (i.e.,
1.100.697) extra for the offered health gain.
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OE-WTP value than PS-5 (p = 0.00), along the lines of
the uncorrected results reported in Table 2. The con-
clusions of model 1 do not change when risk and health
gain are separately included in the regression (although
it shows that risk level 50 % had the highest positive
influence on OE-WTP) (model 2).
In terms of response patterns (H2), there is mixed evi-
dence. On the one hand, there was no significant difference
between the number of zero responses or response time
between PS-5 and PS-25 (p[ 0.05), and less than 2 % of
respondents indicated zero WTP using either scales (zero
responses were retained in the analysis). On the other hand,
the distribution around the means in PS-5 was smaller than
in PS-25 (Levene’s test for the homogeneity of variances
significant, p\ 0.05), and less than 4 % of respondents
opted for an OE-25A in the upper quarter of the value range
of PS-25 as compared to 27 % of respondents solving PS-5
(p\ 0.05). The number of prototypical, rounded values
(ending in 5 or 10) stated in OE-25A was considerably
higher than in OE-5A (37[ 13 %, p\ 0.05) (Table 4).
Non-rounded values are, on the other hand, quite similar in
terms of frequencies between PS-5 and PS-25. 78 % of
OE-5A values were equal to value points offered on PS-5,
relative to 51 % in PS-25 (Table 4; Fig. 2). Finally, larger
intervals between the value points seemingly lead to
rounding. In PS-5, after the amount of €250, all respon-
dents rounded their WTP to the nearest multiple of €50
(i.e., €350, €450). In PS-25, after the amount of €750, all
respondents rounded their WTP to the nearest €100 (i.e.,
€1400 or €1600).
Table 2 QALY gain, PS value
range, and OE-WTP (monthly;
in €)
Variable PS-5 PS-25 p
Average SD Average SD
PSL,A 36.98 79.18 115.77 312.75 0.000
OE-WTP 53.36 91.91 154.21 351.27 0.000
PSU,A 115.28 167.78 358.56 675.60 0.000
Expected QALY gain 0.087 0.148 0.096 0.165 0.054
WTP per QALY (per year*) 227,200 404,400 0.000
n 508 507
* Monthly values multiplied by 12
Table 3 Results of multivariate regression analysis with Log(OE-WTP) as the dependant variable (n = 936)
Variable Model 1 Model 2 Model 3
Coefficient SE p Coefficient SE p Coefficient SE p
log(expected health gaina) 0.128 0.027 0.000 0.861 0.028 0.003 0.09 0.023 0.000
Age -0.021 0.004 0.000 -0.199 0.003 0.000 -0.019 0.003 0.000
log(income) 0.697 0.098 0.000 0.578 0.088 0.000 0.531 0.089 0.000
Education (high = 1) 0.146 0.108 0.177 0.024 0.031 0.41 0.032 0.031 0.295
Gender (female = 1) 0.180 0.101 0.075 0.141 0.089 0.115 0.132 0.089 0.141
Payment scale (PS-25 = 1) 0.896 0.100 0.000 0.917 0.089 0.000 0.842 0.165 0.000
Constant -1.311 0.769 0.089 -0.735 0.680 0.281 -0.048 0.687 0.944
Risk 2 % Omitted
Risk 4 % 0.095 0.126 0.448
Risk 10 % 0.109 0.132 0.408
Risk 50 % 0.305 0.124 0.015
PS*certainty level 0.077 0.167 0.644
R2 0.172 0.191
a The level of health risk presented in scenarios is a part of the expected QALY gain, which is a multiplication of the level of risk and the size of
the health gain (or the difference between the utility weightings of the two EQ 5D health states offered in each scenario)
Table 4 Frequencies table (PS-5 and PS-25)
PS-5 PS-25
Freq. % Freq. %
Amount (already) on scale (value point) 395 77.8 258 50.9
Non-rounded amount (not on scale) 47 9.3 60 11.8
Rounded amount (not on scale) 66 13.0 189 37.3
n 508 100 507 100
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Figure 3 presents the average value gaps and the cor-
responding OE-25A and OE-5A. PS-25 yielded values that
were clearly concentrated around the mid-point; OE-25A
fell almost at the centre of the PS-25L, A–PS-25U, A value
range. When deleting extreme values at (or beyond) the
very extreme of PS-25 ([€2000; n = 7), the monthly OE-
25A was €122, which is almost exactly in the middle of PS-
25. On the contrary, PS-5 did not result in a high con-
centration of average values around the mid-point, hence
confirming H3.
Respondents who used PS-5 reported relatively more
certainty regarding their hypothetical WTP values, both in
terms of narrower value gaps and in terms of post-
estimation uncertainty, revealing some support for H4. The
average value gap for PS-5 was €78 and for PS-25 was
€243 (p = 0.00, Fig. 3). This is approx. a factor three
difference, similar to the factor three difference in OE-
WTP. If the width of the value gap is taken as an indication
of preference uncertainty (where wider gap = more
uncertainty), then the level of response certainty was on
average higher in PS-5 than PS-25. Similarly, the post-
estimation self-assessed certainty was also higher follow-
ing PS-5 than PS-25 (p = 0.038). A somewhat higher
proportion of respondents were pretty sure or totally sure
that they would pay the OE-5 if they had to do so right
now, relative to OE-25 (Fig. 4). The correlation between
Fig. 2 Most frequently stated maximum WTP OE, obtained following PS-5 and PS-25 (here presented on PS-5 and PS-25
Fig. 3 Respondents’ WTP value gaps and related maximum OE-WTP (monthly values*) Note: L lower end of the value gap; U upper end of the
value gap; A average. *To obtain yearly values, monthly values should be multiplied by 12
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the width of the value gap and the self-reported certainty is,
however, negligible (r = 0.1, p = 0.018 in PS-25 and
r = 0.01, p = 0.7 in PS-25), indicating that the two
methods of capturing uncertainty may not be representing
the same underlying preferences.
There is no correlation between OE-WTP and post-
estimation certainty (r = -0.018, p = 0.55). However,
to test whether the conclusion regarding the relationship
between PS design and OE-WTP changes when we
explicitly account for preference uncertainty, we inclu-
ded an interaction between the PS dummy and the level
of post-estimation certainty in model 3 (Table 3).
Although post-estimation uncertainty assessment was
performed after OE-WTP was elicited, it may reflect
some level of inherent respondents’ uncertainty, which
may drive the OE-WTP instead of (or alongside) the PS
design. However, the interaction term is insignificant,
indicating that the association between the OE-WTP and
the PS design is likely independent from response
uncertainty when uncertainty is measure using post-es-
timation self-assessment.
Discussion
This study explored the sensitivity of WTP estimates for
health gains to PS design. If respondents have stable,
well-formed preferences, the WTP value they express is
expected to be independent from the PS design, or any
other aspect of a contingent valuation question. However,
in case preferences are not stable or well formed, the
resulting value may be influenced by the characteristics of
the PS. The findings described in this paper confirm that
the outcome of a contingent valuation study employing a
payment scale can indeed be influenced by the design of
this payment scale, to a considerable extent. Although we
have illustrated this sensitivity with just one WTP ques-
tion, it is likely that the choices regarding the payment
scale (i.e., range, intervals, distributions of values, etc.)
will be a fundamental issue in any contingent valuation
study.
Non-market valuations are necessary in certain cir-
cumstances, for instance when revealed preferences are
not available. Different WTP per QALY estimates used
in a cost-benefit analysis may lead to different conclu-
sions of the social welfare impact of an intervention.
Hence, it would be constructive to think of how survey
methods can be improved in order to obtain results that
are more reliable. In the context of this study, it would
therefore be relevant to discuss whether PS-5 or PS-25
performed ‘‘better’’, and if so, why. To make inferences
about the ‘‘goodness’’ of PS-5 and PS-25, we tested
different features of WTP estimates obtained using the
two scales.
In particular, PS-5 yielded OE-5A values surrounded
by relatively more response certainty, suggesting that it
may have increased reliability relative to PS-25. We
base this argument on previous experimental evidence
suggesting that WTP values surrounded by more cer-
tainty correlate better with the actual, or observed,
consumption behavior (e.g., [6]). If the degree of accu-
racy of WTP estimates can be measured by the strength
of correlation between the WTP and actual consumption
behavior, higher levels of post-estimation certainty and
narrower value gaps may provide an indication of the
‘‘goodness’’ of the PS. Here, ‘‘better’’ means more
accurate, and according to the certainty criterion, PS-5
appears to be the better scale.
Fig. 4 Response certainty
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Moreover, the larger central tendency of the PS-25 and
OE-25 estimates may also be taken as indication the PS-25
is a poorer vehicle for preference expression. Generally
speaking, a neutral mid-point in the response scale can
serve as an anchor point to respondents [3, 47], especially
for respondents whose preferences are not well formed
[52]. Given the similarity of our split samples and the
health gain sizes on offer, one interpretation of the central
tendency of PS-25 is that this PS led more respondents who
were uncertain about their WTP to base their valuation on
the ‘‘easy cue’’—the mid-point.
The question now is why PS-5 would perform better in
this setting. First, smaller value points presented on PS-5
may better reflect the context of payments through health
insurance, described in our contingent market. Respondents
may be more familiar with smaller values in their daily
reasoning, for instance when thinking of health insurance
premiums, and hence be better at discriminating between
values in the lower end of the value range, which were
better represented in PS-5. Second, PS-5 is a less coarse
scale, i.e., a scale with a higher number of value points and
(relatively) smaller intervals, and more exact values.
Coarseness is important because the respondent uses the PS
to convert (or map) her true WTP into a position on the PS,
and if the scale is too coarse it may lead to information loss
and provide a less accurate reflection of ‘true’ values7
([1, 51, 55]). In other words, if PS is characterized by a
higher degree of exactness, it may evoke more exact OE-
WTP values (e.g., [67]). However, although PS-5 was a
less coarse and a more exact scale, and hence perhaps a
better vehicle for expressing respondents’ preferences, the
question of how many scale points is optimal remains
unsolved [60]. Analyzing the scales used to report
respondents’ attitudes (not WTP), Goggin and Stoker [27]
found that the costs of employing an unduly coarse mea-
sure are significant, in terms of lowered reliability, validity,
the associated biases and power limitations in statistical
estimation. Although measures that are needlessly coarse
and those that are needlessly fine-grained each have their
problems, ‘‘scholars should err in the direction of seeking
more fine-grained rather than less fine-grained measures’’
[27].
Although optimal PS design for every specific CV
context may remain unattainable, we may considerably
improve our designs and survey instruments by careful
scale pretesting––and the same could be said for all other
questionnaire formats. Pretesting is crucial because, as this
study shows, the resulting value of a health gain can be
manipulated by decisions regarding the payment scale,
which decreases the usefulness of CV research. So far,
however, the pretesting of payment scales seems largely
confined to exploring whether unrealistically high end-
points were present on the scale (which is judged by
observing frequencies with which highest values are cho-
sen, e.g., [8]). We argue that additional criteria should be
introduced, such as sensitivity to mid-points or the width of
value gaps. Pretesting could identify the approximate
marginal distribution of values in the population and could
avert the use of inappropriate payment scales. Several PS
may need to be pretested while designing a CV study (and
not a single scale, which is then collapsed or extended,
depending on frequency testing; e.g., [9]), and a description
of pretesting procedures should be provided for evaluators
of contingent valuation studies. Once the analyst observes
that the scales are largely insensitive to, for instance, the
end-points and mid-points of the scale, and that post-esti-
mation certainty increases and value gaps narrow, she
could be more confident in using the scale. Work from
other areas may also be very helpful in designing better PS
scales (e.g., [65]) and devising protocols for scale pretest-
ing. Pretesting should reduce the dependency of WTP on
PS design and increase the reliability of WTP estimates.
One of the main limitations of our study is our inability
to fully distinguish between the effects of each feature of
PS on WTP, due to the multiple differences between PS-5
and PS-25. We cannot exclude a possibility of a combined
effect of different scale features, nor can we be certain
which feature of PS is most prominent. The aim of this
study was not to single out the effect of each particular
feature of PS on WTP, but to show how two distinct
designs can lead to considerable differences in WTP. It
would be interesting to repeat this research in a different
setting where each of the features of PS could be investi-
gated independently, preferably in an experimental study
involving actual payments. It would be interesting to test
the impact of PS design on WTP values for more familiar,
‘‘every-day’’ goods. Placing a monetary value on a health
gain is a difficult exercise. Although the study design
strived to help respondents understand the gain under
valuation (e.g., using graphical explanations), it is still
possible that the PS design would have had less effect on
the monetary value of a familiar good, due to known ref-
erence prices, better-formed preferences or experience in
trading. For instance, a WTP exercise aimed at valuing a
new type of bread may not be as affected by the PS design
as the value of a QALY was, which may reduce the gen-
eralizability of our findings. On the other hand, the WTP
question analyzed in this paper was the third consecutive
question presented in the online contingent valuation study,
7 For instance, if the ‘‘true’’ WTP value of a respondent is €50 for the
offered health gain and the PS ranges from €0 to €500 with only 4
value points (e.g., 1, 100, 250, and 500) then the respondent needs to
round her ‘‘true’’ value to the closest value point, either €1 or €100.
Obviously, taking the either estimate as respondent’s WTP will lead
to information loss and yield inaccurate WTP values (if inferred only
from the PS, without OE-WTP).
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following two very similar WTP per QALY questions
(reported in [9]). The difference between the third and the
preceding two questions was only in the payment method
(out-of-pocket vs. health insurance) and the experience
respondents gained by solving two initial WTP questions
may have somewhat reduced the unfamiliarity with the
good under valuation and the valuation process itself,
which may have a positive impact on the generalizability
of our findings. This is, however, difficult to test. Under-
standing exactly how respondents perceive and complete
payment scales could further help the development of PS
yielding more reliable WTP estimates.
A second limitation of this study may lie with the data
collection method. We used an online survey, which lim-
ited our ability to foster respondent engagement or reflec-
tion while solving the questionnaire. If preferences are
constructed or learned during survey completion (espe-
cially for unfamiliar goods, e.g., [4, 43]), online surveys
may provide highly contingent results [50] that may not be
close representations of the ‘‘true’’ underlying values. In
terms of engagement and reflection, face-to-face interviews
have been the recommended as the ‘‘gold standard’’ [45].
However, recent research exploring the effects of different
survey modes on how preferences are formed and stated
(e.g., [18, 19]) shows in fact that the data obtained from
online surveys and face-to-face interviews are not sub-
stantially different (further discussion in [39]). On the other
hand, the online survey mode has advantages, such as
relatively easy access to geographically spread respondents
at lower cost, the opportunity to use interactive designs and
graphical illustrations and so create more easily under-
standable studies, as well as allowing respondents to
answer in their own time. Still, issues like population
representation in an online panel should be further
addressed since this is important for delivering reliable
welfare estimates for social policy assessment. Thirdly,
examining predictive validity or test–retest reliability may
lead to different conclusions about the efficacy of the PS
than what we present here, and experimental evidence may
add to the reliability of our findings. Finally, while this
study cannot fully discern all the mechanisms leading to
different WTP per QALY estimates obtained using dif-
ferent payment scales, and some mechanisms may be
working in combination or in different directions, it does
reveal that the design of payment scales is not a choice to
be taken lightly. It is hoped that this article will stimulate
researchers to improve PS design. Each research context
may even require its own, a priori unknown, ‘‘optimal
scale’’ and it is therefore important to test the appropri-
ateness of several PS designs before learning what is the
optimal type of scale for a particular context. Pretesting
procedures are thus important to reach correct interpreta-
tions and valid inferences and hence improve welfare
assessment based on social preferences measured using
contingent valuation. For policy-makers the results of this
study are important because they show how manipulations
can affect the results of a CV study, and therefore how
important it is to understand the determinants of (the reli-
ability of) WTP values.
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Appendix 1: Example of a WTP question
from the questionnaire (translated text and screen
prints)
[Introduction to WTP questions] ‘‘Imagine that you are
currently in the health state you just described as better and
that tomorrow you face going to the health state you
described as worse for a period of 1 year. After this year
experiencing the worse health state, you will return back to
the better health state. Now, rather than spending a year in
the worse health state, you could avoid this and remain in
the better health state instead. For this, you will have to
take a painless pill each month during that year. You will
have to pay for these pills yourself, from your (household)
income, through an increase in your health insurance pre-
mium. Have your ability to pay (given your household
income) in mind!!’’
The text in the text boxes provides a description of the
two health states, using EQ5D-3L classification, which
varied between scenarios. In this example, the translation
of the health states is: (for the top text box) I have no
problems walking about, I have no problems dressing or
washing myself, I have no problems with daily activities, I
feel mild pain or discomfort, I am mildly depressed or
anxious; (for the bottom box) I have some problems
walking about; I have some problems dressing or washing
myself; I have no problems with daily activities; I feel mild
pain or discomfort; I am mildly depressed or anxious.
L. Soeteman et al.
123
Payment scale format, lower bound. ‘‘Suppose you
would have to pay an amount for this pill right now. Please
consider the range of amounts below. Now, start from the
left and tick the highest amount you would definitely pay
for this pill on a monthly basis for the duration of 1 year to
avoid going to the worse health state.’’
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Payment scale format, upper bound. ‘‘Next, continue
moving up the line and tick the first amount you would
definitely not pay for this pill on a monthly basis for the
duration of 1 year to avoid going to the worse health
state.’’
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Open-ended format. ‘‘You have indicated that you
would definitely pay €50 and definitely not pay €150 to
avoid experiencing the worse health state for 1 year and
remaining in the better health state. Please write in the
amount (between €50 and €150) that most closely
approximates the maximum you would be willing to pay
per month to avoid going to the worse health state?’’
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Certainty level: ‘‘You have indicated that you would
definitely pay €50 and definitely not pay €150 to avoid
experiencing the worse health state for 1 year and
remaining in the better health state. How certain are you
that you would pay the stated amount, if asked to do so
right now?’’
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Appendix 2: The graphical explanation
of the concept of risk
A 10 9 10 matrix of green dots represented a hundred
people—each dot being an individual ‘‘just like you’’. To
demonstrate the meaning of, say, a 40 % chance of
becoming ill, we asked respondents to click on one of the
green dots (clicking superimposed a black ‘‘x’’ on the dot).
Respondents were told that the computer then randomly
selected 40 of the hundred dots and turned them red; the
chance that the dot they marked would turn red was 40 in
100, or 40 %. The same example was repeated with a 1 %
chance.
Translation from Dutch: ‘‘Now imagine that in this
group of 100 people the probability that someone becomes
ill rises to 40 %. In other words, 40 people will become ill
and 60 people will not. To get an idea of what it means for
the probability that you will be one of the people becoming
ill, choose a green dot and click on it. The probability of
the dot you selected changing color is 40 to 100.’’
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Appendix 3: Design of the choice scenarios, levels
of risk, and expected QALY gain
Choice scenario Health state 1 Health state 2 Level of risk (%)
1 22222 11131 10
2 33232 33323 50
3 21312 12111 2
4 22323 21312 2
5 22323 12111 2
6 21232 32211 4
7 11112 22121 10
8 11122 22122 10
9 21323 22233 4
10 22331 21133 4
11 21111 12121 50
12 23232 32232 50
13 11312 11113 10
14 12311 11211 2
15 32311 12311 10
16 32311 11211 2
17 21111 12211 50
18 32313 32331 50
19 11211 22211 4
20 23313 11133 50
21 11121 22112 10
22 12223 13332 10
23 11312 11211 2
24 11332 11312 4
25 11332 11211 2
26 21222 33321 2
27 22222 13311 50
28 11112 22112 4
29 33212 32223 4
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